Jazz Pharmaceuticals (JAZZ) Construction in Progress (2010 - 2016)

Jazz Pharmaceuticals' Construction in Progress history runs 7 years deep, the most recent figure standing at $66.2 million for Q1 2016.

• On a quarterly basis, Construction in Progress rose 33.85% year-over-year to $66.2 million in Q1 2016; TTM through Mar 2016 was $66.2 million, a 33.85% increase from a year earlier, with the FY2015 full-year figure at $63.0 million, up 69.63% from the prior year.
• Construction in Progress advanced to $66.2 million in Q1 2016 per JAZZ's latest filing, from $63.0 million in the prior quarter.
• Across five years, Construction in Progress topped out at $66.2 million in Q1 2016 and bottomed at $148000.0 in Q1 2012.
• The 5-year median for Construction in Progress is $10.6 million (2014), against an average of $24.0 million.
• Across the five-year window, Construction in Progress soared 1239.19% in 2013 and soared 33.85% in 2016, its largest moves.
• Year by year, Construction in Progress stood at $1.1 million in 2012, then surged by 286.61% to $4.4 million in 2013, then surged by 746.51% to $37.1 million in 2014, then jumped by 69.63% to $63.0 million in 2015, then gained by 5.04% to $66.2 million in 2016.
• Per Business Quant, the three latest JAZZ Construction in Progress figures stand at $66.2 million (Q1 2016), $63.0 million (Q4 2015), and $61.1 million (Q3 2015).